how long have glp 1 medications been around GLP-1 are transforming diabetes and weight loss treatment Overview of GLP-1s

Understanding clinical criteria, biomarker context, and how healthcare providers evaluate eligibility helps non-overweight patients m

With advancements in weight-loss treatments, options like glucagon-like peptide-1 (GLP-1) receptor agonists and bariatric surgery are helping individuals achieve their goals.

Citing its post-market evaluation that found no increased risk of suicidal ideation or behavior, the U.S

Therefore, although DPP-4 inhibitors have attractive clinical features, the benefits that might be expected from GLP-1 signaling may be undermined by their actions to enhance SDF-1.

Methods We selected individuals aged 45 years and older already treated with metformin living in Lombardy, Italy, and then split them into two groups if they initiated GLP-1 RAs or other antidiabetic drugs, between 2019 and 2021